Nur77 is involved in glutamine metabolism in rhabdomyosarcoma by inhibiting the β-catenin/Myc signaling pathway, which results in a decrease in β-catenin and c-Myc levels [45]. This evidence concerns the gene NR4A1 and rhabdomyosarcoma.